MediCom Oncology Clinical Pearls Podcasts

MediCom Oncology
  • 4.5 (2)
  • SCIENCE
MediCom Oncology Clinical Pearls Podcasts

MediCom Oncology Clinical Pearl Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting, in under three minutes. Leading experts and academic faculty from top research and practice institutions provide guidance to community-based healthcare providers, including oncologists, pharmacists and nurses. Podcasts are brought to you by MediCom Worldwide, Inc., an accredited, independent medical education company. Podcasts are intended for licensed adult healthcare professionals (HCPs). HCPs should exercise professional judgment in evaluating content, and confirm information before implementing treatment or practice-related changes. Podcasts do not provide medical advice to patients.

  1. Third-generation FLT3 inhibitors in clinical development

    10/26/2018

    Third-generation FLT3 inhibitors in clinical development

    Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.

    3 min
  2. CAR T case study in acute myeloid leukemia

    10/05/2018

    CAR T case study in acute myeloid leukemia

    Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.

    6 min
  3. Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi

    10/05/2018

    Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi

    Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.

    2 min
  4. How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance

    03/20/2018

    How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance

    In this audio activity, Dr. Goldberg describes his approach to patients with idiopathic or clonal cytopenias of undetermined significance (ICUS and CCUS).

    4 min
  5. When to consider iron chelation therapy for a transplant-eligible patient

    03/20/2018

    When to consider iron chelation therapy for a transplant-eligible patient

    Listen as Dr. Goldberg explains his approach to iron chelation therapy in patients who are, or may be within the next 5-10 years, eligible for transplant.

    4 min
  6. 53-year-old woman presenting with severe fatigue and bruising

    03/20/2018

    53-year-old woman presenting with severe fatigue and bruising

    Hematopathologist Dr. Khoury presents a case snapshot showing the complexities of diagnosing AML, describing the importance of morphology, flow cytometry, cytogenetics, and molecular diagnostics.

    4 min
  7. New subcategories of pancreatic cancer allow for a biomarker-driven approach to therapy

    01/05/2018

    New subcategories of pancreatic cancer allow for a biomarker-driven approach to therapy

    Dr. O'Reilly discusses the new subcategories of pancreatic cancer that have emerged, and which are laying the groundwork for a biomarker-driven approach to therapy.

    4 min
  8. What are the unique aspects of pancreas cancer that lead to the development of novel therapeutics?

    01/05/2018

    What are the unique aspects of pancreas cancer that lead to the development of novel therapeutics?

    Dr. O'Reilly discusses the unique pathophysiology of pancreas cancer that must be considered in the development of novel therapeutics.

    3 min
See All (53)

Ratings & Reviews

4.5
out of 5
2 Ratings

About

MediCom Oncology Clinical Pearl Podcasts provide practical, evidence-based recommendations on real-world issues in the clinical setting, in under three minutes. Leading experts and academic faculty from top research and practice institutions provide guidance to community-based healthcare providers, including oncologists, pharmacists and nurses. Podcasts are brought to you by MediCom Worldwide, Inc., an accredited, independent medical education company. Podcasts are intended for licensed adult healthcare professionals (HCPs). HCPs should exercise professional judgment in evaluating content, and confirm information before implementing treatment or practice-related changes. Podcasts do not provide medical advice to patients.

Information

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada